Conjugation of biogenic and synthetic polyamines with serum proteins: A comprehensive review

International Journal of Biological Macromolecules

Volumn 92, Issue , 2016, Pages 515-522

  Chanphai, P ^a   Thomas, T J ^b   Tajmir Riahi, H A ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Conjugation; Drug delivery; Modeling; Polyamine; Serum protein

Indexed keywords

3,7,11,15 TETRAZAHEPTADECANE; 3,7,11,15,19 PENTAZAHENICOSANE; BETA LACTOGLOBULIN; BIOGENIC AMINE; BOVINE SERUM ALBUMIN; HUMAN SERUM ALBUMIN; HYDROGEN; PLASMA PROTEIN; POLYAMINE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG; AMINO ACID; LACTOGLOBULIN; SERUM ALBUMIN;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; COMPLEX FORMATION; CONJUGATION; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; HYDROGEN BOND; HYDROPHILICITY; INFRARED SPECTROSCOPY; MOLECULAR MODEL; PH; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SPECTROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY CRYSTALLOGRAPHY; ANIMAL; BINDING SITE; BOVINE; CHEMISTRY; HUMAN; KINETICS; METABOLISM; MOLECULAR DOCKING; ULTRAVIOLET SPECTROPHOTOMETRY;

AMINO ACIDS; ANIMALS; BINDING SITES; BIOGENIC POLYAMINES; CATTLE; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LACTOGLOBULINS; MOLECULAR DOCKING SIMULATION; PROTEIN STRUCTURE, SECONDARY; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84989925262     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.07.049     Document Type: Article

References (68)

1. [1] Igarashi, K., kashiwagi, K., Modulation of cellular function by polyamines. Int. J. Biochem. Cell Biol. 42 (2010), 39–51.
2. [2] Pegg, A.E., Mammalian polyamine metabolism and function. IUBMB Life 61 (2009), 880–894.
3. [3] Heby, O., Role of polyamines in the control of cell proliferation and differentiation. Differentiation 19 (1981), 1–20 61 (2009) 880–894.
4. [4] Agostinelli, E., Polyamines and transglutaminases: biological, clinical, and biotechnological perspectives. Amino Acids 46 (2014), 475–485.
5. [5] Thomas, T., Thomas, T.J., Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell. Mol. Life Sci. 58 (2001), 244–258.
6. [6] Pegg, A.E., Polyamine metabolism, and its importance in neoplastic growth and a target of chemotherapy. Cancer Res. 48 (1988), 759–774.
7. [7] Shah, N., Thomas, T.J., Lewis, L.S., Klinge, C.M., Shirahata, A., Gelinas, C., Thomas, T., Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Oncogene 20 (2001), 1715–1729.
8. [8] Shah, N., Thomas, T., Shirahata, A., Sigal, L.H., Thomas, T.J., Activation of nuclear factor kappaB by polyamines in breast cancer cells. Biochemistry 38 (1999), 14763–14774.
9. [9] Huang, Y., Keen, J.C., Pledgie, A., Marton, L.J., Zhu, T., Skummar, S., Park, B.H., Blair, B., Brenner, K., Castro, R.A. Jr., Davidson, N.E., Polyamine analogues down- regulate estrogen receptor α expression in human breast cancer cells. J. Biol. Chem 281 (2006), 19055–19063.
10. [10] Huang, Y., Keen, J.C., Hager, E., Smith, R., Hacker, A., Frydman, B., Valasinas, A.L., Reddy, V.K., Marton, L.J., Castro, R.A. Jr., Davidson, N.E., Regulation of polyamine analogue cytotoxicity by c-jun in human MDA-MB-435 cancer cells. Mol. Cancer Res. 2 (2004), 81–88.
11. [11] Casero, R.A. Jr., Woster, P.M., Terminally alkylated polyamine analogues as chemotherapeutic agents. J. Med. Chem. 44 (2001), 1–26.
12. [12] Bergeron, R.J., Neims, A.T., McManis, J.S., Hawthorne, T.R., Vinson, J.R.T., Bortell, R., Ingeno, M.J., Synthetic polyamines analogues as antineoplastics. J. Med. Chem. 31 (1988), 1183–1190.
13. [13] Thomas, T., Thomas, T.J., Polyamine metabolism and cancer. J. Cell. Mol. Med. 7 (2003), 113–126.
14. [14] Nowotarski, S.L., Woster, P.M., Casero, R.A. Jr., Polyamines and cancer: implications for chemoprevention and chemotherapy. Expert Rev. Mol. Med., 213, 2016 15: e3.
15. [15] Thomas, T., Balabhadrapathruni, S., Gallo, M.A., Thomas, T.J., Development of polyamine analogs as cancer therapeutic agents. Oncol. Res. 13 (2002), 123–135.
16. [16] Ha, H.C., Woster, P.A., Yager, J.D., Casero, R.A. Jr., The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 11557–11562.
17. [17] Ha, H.C., Sirisoma, N.S., Kuppusamy, P., Zweier, J.L., Woster, P.M., Casero, R.A. Jr., The natural polyamines spermine functions directly as a free radical scavenger. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 11140–11145.
18. [18] Faaland, C.A., Thomas, T.J., Balabhadrapathruni, S., Langer, T., Mian, S., Shirahata, A., Gallo, M.A., Thomas, T., Molecular correlates of the action of bis(ethyl)polyamines in breast cancer cell growth inhibition and apoptosis. Biochem. Cell Biol. 78 (2000), 415–426.
19. [19] Kostopoulou, O.N., Kouvela, E.C., Magoulas, G.E., Garnelis, T., Panagoulias, I., Rodi, M., Papadopoulos, G., Mouzaki, A., Dinos, G.P., Papaioannou, D., Kalpaxis, D.L., Conjugation with polyamines enhances theantibacterial and anticancer activity of chloramphenicol. Nucleic Acids Res. 42 (2014), 8621–8634.
20. [20] Thomas, T.J., Tajmir-Riahi, H.A., Thomas, T., Polyamine-DNA interactions and development of gene delivery vehicles. Amino Acids, 2016, 10.1007/s00726-016-2246-8.
21. [21] Gerner, W.E., Meyskens, F.L. Jr., Polyamines and cancer: old molecules, new understanding. Nat. Rev. Cancer 4 (2004), 781–792.
22. [22] Vijayanathan, V., Thomas, T., Thomas, T.J., DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry 41 (2002), 14085–14094.
23. [23] Vijayanathan, V., Agostinelli, E., Thomas, T., Thomas, T.J., Innovative approaches to the use of polyamines for DNA nanoparticle preparation for gene therapy. Amino Acids 46 (2014), 499–509.
24. [24] Agostinelli, E., Vianello, F., Magliulo, G., Thomas, T., Thomas, T.J., Nanoparticle strategies for cancer therapeutics: nucleic acids, polyamines, bovine serum amine oxidase and iron oxide nanoparticles (review). Int. J. Oncol. 46 (2015), 5–16.
25. [25] Sanyakamdhorn, S., Chanphai, P., Tajmir-Riahi, H.A., Encapsulation of biogenic and synthetic polyamines by nanoparticles PEG and mPEG-anthracene. J. Photochem. Photobiol. B 130 (2014), 30–39.
26. [26] Chanphai, P., Tajmir-Riahi, H.A., Trypsin and trypsin inhibitor bind PAMAM nanoparticles: effect of hydrophobicity on protein–polymer conjugation. J. Colloid Interface Sci. 461 (2016), 419–424.
27. [27] Mandeville, J.S., Bourassa, P., Thomas, T.J., Tajmir-Riahi, H.A., Biogenic and synthetic polyamines bind cationic dendrimers. PLoS One, 7(4), 2016, e36087.
28. [28] Beauchemin, R., N'soukpoe-Kossi, C.N., Thomas, T.J., Thomas, T., Carpentier, R., Tajmir-Riahi, H.A., Polyamine analogues bind human serum albumin. Biomacromolecules 8 (2007), 3177–3183.
29. [29] Dubeau, S., Bourassa, P., Thomas, T.J., Tajmir-Riahi, H.A., Biogenic and synthetic polyamines bind bovine serum albumin. Biomacromolecules 11 (2010), 1507–1515.
30. [30] Essemine, J., Hasni, I., Carpentier, R., Thomas, T.J., Tajmir-Riah, H.A., Binding of biogenic and synthetic polyamines to beta-lactoglobulin. Int. J. Biol. Macromol. 49 (2011), 201–209.
31. [31] Ahmed Ouameur, A., Mangier, E., Diamantoglou, S., Rouillon, R., Carpentier, R., Tajmir-Riahi, H.A., Effects of organic and inorganic polyamine cations on the structure of human serum albumin. Biopolymers 73 (2004), 503–509.
32. [32] Elsadek, B., Kratz, F., Impact of albumin on drug-delivery-new application on the horizon. J. Control. Release 157 (2012), 4–28.
33. [33] Kratz, F., Elsadek, B., Clinical impact of serum proteins on drug delivery. J. Control. Release 161 (2012), 429–445.
34. [34] Kratz, F., Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 132 (2008), 171–183.
35. [35] Agudelo, D., Berube, G., Tajmir-Riahi, H.A., An overview on the delivery of antitumor drug doxorubicin by carrier proteins. Int. J. Biol. Macromol. 88 (2016), 354–360.
36. [36] Chanphai, P., Vesper, A.R., Bariyanga, J., Berube, G., Tajmir-Riahi, H.A., Review on the delivery of steroids by carrier proteins. J. Photochem. Photobiol. B, 2016 in press.
37. [37] Yang, F., Zhang, Y., Liang, H., Interactive association of drugs binding to human serum albumin. Int. J. Mol. Sci. 15 (2014), 3580–3595.
38. [38] Ghuman, J., Zunszain, P.A., Petitpas, I., Bhattacharya, A.A., Otagiri, M., Curry, S., Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353 (2005), 38–52.
39. [39] Liang, L., Tajmir-Riahi, H.A., Subirade, M., Interaction of β-lactoglobulin with resveratrol and its biological implications. Biomacromolecules 9 (2008), 50–55.
40. [40] Liang, L., Subirad, M., β-lactoglobulin/folic acid complexes: formation, characterization, and biological implication. J. Phys. Chem. B 114 (2010), 6707–6712.
41. [41] Akdogan, Y., Reichenwallner, J., Hinderberger, D., Evidence for water-tuned structural differences in proteins: an approach emphasizing variations in local hydrophilicity. PLoS One, 7, 2012 1–11, e456810.
42. [42] Jameson, G.B., Adams, J.J., Creamer, L.K., Flexibility, functionality and hydrophobicity of bovine β-lactoglobulin. Int. Dairy J. 12 (2002), 319–329.
43. [43] Loch, J.I., Bonarek, P., Polit, A., Swiatek, S., Czuba, M., Ludwikowska, M., Lewinski, K., Conformational variability of goat beta-lactoglobulin: crystallographic and thermodynamic studies. Int. J. Biol. Macromol. 72 (2015), 1283–1291.
44. [44] Sugio, S., Kashima, A., Mochizuki, S., Noda, M., Kobayashi, K., Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12 (1999), 439–444.
45. [45] Arnold, K., Bordoli, A.K., Kopp, L., Schwede, T., A web-based environment for protein structure homology modeling. Bioinformatics 22 (2006), 195–201.
46. [46] Rost, B., Twilight zone of protein sequence alignment. Protein Eng. 12 (1999), 85–94.
47. [47] Bourassa, P., Hasni, I., Tajmir-Riahi, H.A., Folic acid complexes with human and bovine serum albumins. Food Chem. 129 (2011), 1148–1155.
48. [48] Connors, K., Binding Constants: The Measurement of Molecular Complex Stability. 1987, John Wiley & Sons, New York.
49. [49] Dousseau, F., Therrien, M., Pezolet, M., On the spectral subtraction of water from the FT-IR spectra of aqueous solutions of proteins. Appl. Spectrosc. 43 (1989), 538–542.
50. [50] Byler, D.M., Susi, H., Examination of the secondary structure of proteins by deconvoluted FTIR spectra. Biopolymers 25 (1986), 469–487.
51. [51] Chandra, S., Dietrich, S., Lang, H., Bahadur, D., Dendrimer–doxorubicin conjugate for enhanced therapeutic effects for cancer. J. Mater. Chem. 21 (2011), 5729–5737.
52. [52] Krimm, S., Bandekar, J., Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv. Protein. Chem. 38 (1986), 181–364.
53. [53] Chanphai, P., Bekale, L., Tajmir-Riahi, H.A., Effect of hydrophobicity on protein–protein interactions. Eur. Polymer J. 67 (2015), 224–231.
54. [54] Tian, J., Liu, J., Hu, Z., Chen, X., Binding of the scutellarin to albumin using tryptophan fluorescence quenching, CD and FT-IR spectra. Am. J. Immunol. 1 (2005), 21–23.
55. [55] Grdadolnik, J., Saturation effects in FTIR spectroscopy: intensity of amide I and amide II bands in protein spectra. Acta Chim. Slov. 50 (2003), 777–788.
56. [56] Gokara, M., Kimavathb, G.B., Podileb, A.R., Subramanyam, R., Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein. J. Biomol. Struct. Dyn. 33 (2014), 196–210.
57. [57] Yeggoni, D.P., Gokara, M., Manidhar, D.M., Rachamallu, A., Nakka, S., Reddy, C.S., Subramanyam, R., Binding and molecular dynamics studies of 7- hydroxycoumarin derivatives with human serum albumin and Its pharmacological importance. Mol. Pharm. 11 (2014), 1117–1131.
58. [58] Bekale, L., Agudelo, D., Tajmir-Riahi, H.A., Effect of polymer molecular weight on chitosan–protein interaction. Colloids Surf. B 125 (2015), 309–317.
59. [59] Bekale, L., Chanphai, P., Sanyakamdhorn, S., Agudelo, D., Tajmir-Riahi, H.A., Microscopic and thermodynamic analysis of PEG–beta-lactoglobulin interaction. RSC Adv. 4 (2014), 31084–31093.
60. [60] Chamani, J., Moosavi- Movahedi, A.A., Rajabi, O., Gharanfoli, M., Momen- Heravi, M., Hakimelahi, G.H., Neamati-Baghsiah, A., Varasteh, A.R., Cooperative α-helix formation of β-lactoglobulin induced by sodium n-alkyl sulfates. J. Colloid Interface Sci. 293:2006 (2006), 52–60.
61. [61] Rahnama, E., Mahmoodian-Moghaddam, M., Ahmadi, S.K., Saberi, M.R., Chamani, J., Binding site identification of metformin to human serum albumin and glycated human serum albumin by spectroscopic and molecular modeling techniques: a comparison study. J. Biomol. Struct. Dyn. 33 (2015), 513–533.
62. [62] Chamani, J., Comparison of the conformational stability of the non-native α-helical intermediate of thiol-modified β-lactoglobulin upon interaction with sodium n- alkyl sulfates at two different pH. J. Colloid Interface Sci. 299 (2006), 636–646.
63. [63] Zohoorian-Abootorabi, T., Saneea, H., Iranfar, H., Saberi, M.R., Chamani, J., Separate and simultaneous binding effects through a non-cooperative behavior between cyclophosphamide hydrochloride and fluoxymesterone upon interaction with human serum albumin: multi-spectroscopic and molecular modeling approaches. Spectrochim. Acta A 88 (2012), 171–191.
64. [64] Yeggoni, D.P., Rachamallu, A., Subramanyam, R., A comparative binding mechanism between human serum albumin and a-1-acid glycoprotein with corilagin: biophysical and computational approach. RSC Adv. 6 (2016), 40225–40237.
65. [65] Vijayanathan, V., Thomas, T., Shirahata, A., Thomas, T.J., DNA condensation by polyamines: a laser light scattering study of structural effects. Biochemistry 40 (2001), 13644–13651.
66. [66] Saminathan, M., Thomas, T., Shirahata, A., Pillai, C.K., Thomas, T.J., Polyamine structural effects on the induction and stabilization of liquid crystalline DNA: potential applications to DNA packaging, gene therapy and polyamine therapeutics. Nucleic Acids Res. 30 (2002), 3722–3731.
67. [67] Vijayanathan, V., Thomas, T., Antony, T., Shirahata, A., Thomas, T.J., Formation of DNA nanoparticles in the presence of novel polyamine analogues: a laser light scattering and atomic force microscopic study. Nucleic Acids Res. 32 (2004), 127–134.
68. [68] Todd, B.A., Parsegian, V.A., Shirahata, A., Thomas, T.J., Rau, D.C., Attractive forces between cation condensed DNA double helices. Biophys. J. 94 (2008), 4775–4782.